CVR: 36945125
Previous names: ApS STAKE nr. 5237, Cortris Nordic ApS, 3B-Oncology ApS
Resistance Oncology ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named 3B-Oncology ApS and Cortris Nordic ApS. The management consists of Nils Aage Brünner and Kasper Pasternak Jørgensen. The company is owned by TIMPCO NB ApS, Alexander Meier Holding ApS and Pasternak Holding ApS. The company has 0 employees. In 2025, the company reported a gross profit of DKK -410,610 and a net result of DKK -665,070 compared with DKK -29,048 the year before. Equity amounted to DKK 325,631.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at drive virksomhed med produktion, handel og service inden for life science, hvilket efter direktionens bestemmelse kan ske gennem koncernforbundne selskaber samt hermed beslægtet aktivitet
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | -411 t. | -665 t. | 536 t. | 326 t. | 2 | |
| 2024 | -16 t. | -29 t. | 448 t. | 307 t. | 2 | |
| 2023 | -21 t. | -22 t. | 49 t. | -63 t. | 1 | |
| 2022 | -12 t. | -10 t. | 7 t. | -41 t. | - | |
| 2021 | -10 t. | -9 t. | 6 t. | -31 t. | - | |
| 2020 | -10 t. | -8 t. | 6 t. | -23 t. | - | |
| 2019 | 14 t. | 10 t. | 8 t. | -15 t. | - | |
| 2018 | -15 t. | -13 t. | 43 t. | -25 t. | - | |
| 2017 | 51 t. | 1.1 mio. | 52 t. | -12 t. | 0 |
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringCompared to 412 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Resistance Oncology ApS has published its annual report for 2025. Gross profit came to DKK -410,610, and the net result was DKK -665,070.
As of January 5, 2026, Pasternak Holding ApS is registered as an owner of Resistance Oncology ApS with an ownership share of 50%.
Resistance Oncology ApS has published its annual report for 2024. Gross profit came to DKK -15,712, and the net result was DKK -29,048.
As of June 26, 2025, Alexander Meier Holding ApS is registered as an owner of Resistance Oncology ApS with an ownership share of 5%.
As of May 15, 2025, TIMPCO NB ApS is registered as an owner of Resistance Oncology ApS with an ownership share of 25%.
On November 18, 2024, the company changed its name from 3B-Oncology ApS to Resistance Oncology ApS.
Resistance Oncology ApS has published its annual report for 2023. Gross profit came to DKK -21,005, and the net result was DKK -22,028.
On August 25, 2023, the company changed its name from Cortris Nordic ApS to 3B-Oncology ApS.
Resistance Oncology ApS has published its annual report for 2022. Gross profit came to DKK -11,970, and the net result was DKK -10,252.
As of September 1, 2022, Nils Aage Brünner is registered as director of Resistance Oncology ApS.
Resistance Oncology ApS has published its annual report for 2021. Gross profit came to DKK -10,140, and the net result was DKK -8,615.
As of July 6, 2022, Kasper Pasternak Jørgensen is registered as director of Resistance Oncology ApS.
As of July 6, 2022, Jørgen Peter Jørgensen has stepped down as director of Resistance Oncology ApS.
Resistance Oncology ApS has published its annual report for 2020. Gross profit came to DKK -9,500, and the net result was DKK -7,652.
Resistance Oncology ApS has published its annual report for 2019. Gross profit came to DKK 13,935, and the net result was DKK 9,885.
Resistance Oncology ApS has published its annual report for 2018. Gross profit came to DKK -14,500, and the net result was DKK -12,643.
Resistance Oncology ApS has published its annual report for 2017. Gross profit came to DKK 51,356, and the net result was DKK 1,147,497.
Resistance Oncology ApS has published its interim report for the period July 1, 2015 – December 31, 2016.
As of December 21, 2016, Jørgen Peter Jørgensen is registered as director of Resistance Oncology ApS.
As of December 21, 2016, Morten Fadum Nissen has stepped down as director of Resistance Oncology ApS.
As of December 21, 2016, Kasper Pasternak Jørgensen has stepped down as director of Resistance Oncology ApS.
As of July 2, 2015, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Resistance Oncology ApS.
As of July 2, 2015, Morten Fadum Nissen is registered as director of Resistance Oncology ApS.
As of July 2, 2015, Kasper Pasternak Jørgensen is registered as director of Resistance Oncology ApS.
As of July 2, 2015, Peter Andreas Stakemann has stepped down as adm. dir. of Resistance Oncology ApS.
On July 2, 2015, the company changed its name from ApS STAKE nr. 5237 to Cortris Nordic ApS.
As of July 1, 2015, Peter Andreas Stakemann is registered as adm. dir. of Resistance Oncology ApS.
Resistance Oncology ApS was founded on July 1, 2015.
Companies in the same industry and area
CVR 41183144
CVR 35451307
CVR 36392398
CVR 14479880
CVR 29625867
companydata.dk